Action Potential Venture Capital logo

Action Potential Venture Capital

North America, Massachusetts, United States, Cambridge

Description

Action Potential Venture Capital is a strategic venture capital fund that invests in bioelectronic medicine and technology companies.

Investor Profile

Action Potential Venture Capital has made 26 investments, with 4 in the past 12 months and 15% as lead.

Stage Focus

  • Series C (23%)
  • Series B (19%)
  • Series Unknown (19%)
  • Series A (12%)
  • Series D (12%)
  • Series E (4%)
  • Private Equity (4%)
  • Series G (4%)
  • Series F (4%)

Country Focus

  • United States (92%)
  • Australia (8%)

Industry Focus

  • Medical
  • Health Care
  • Medical Device
  • Biotechnology
  • Therapeutics
  • Health Diagnostics
  • Machinery Manufacturing
  • Product Design
  • Wearables
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Action Potential Venture Capital frequently co-invest with?

Shangbay Capital
North America, California, United States, Palo Alto
Co-Investments: 3
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 3
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 6
Boston Scientific
North America, Massachusetts, United States, Marlborough
Co-Investments: 6
Lightstone Ventures
North America, California, United States, Menlo Park
Co-Investments: 3
Lux Capital
North America, New York, United States, New York
Co-Investments: 3
Morgenthaler Ventures
North America, California, United States, Menlo Park
Co-Investments: 6
Topspin Partners
North America, New York, United States, Mamaroneck
Co-Investments: 3
Medtronic
North America, Minnesota, United States, Minneapolis
Co-Investments: 3
Windham Venture Partners
North America, New York, United States, New York
Co-Investments: 5

Which angels does Action Potential Venture Capital often collaborate with?

AO
North America, New York, United States, Woodmere
Shared Deals: 1

What are some of recent deals done by Action Potential Venture Capital?

MicroTransponder

Dallas, Texas, United States

MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases.

Health CareMedicalMedical Device
Series FMar 12, 2025
Amount Raised: $65,000,000
Saluda Medical

Bloomington, Minnesota, United States

Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions.

Health CareMedicalMedical DeviceTherapeutics
Series UnknownJan 10, 2025
Amount Raised: $100,000,000
Cala Health

San Mateo, California, United States

Cala Health is a bioelectronic medicine company that develops wearable neuromodulation devices for the treatment of chronic diseases.

Health CareMedicalMedical DeviceWearables
Series CDec 9, 2024
Amount Raised: $50,000,000
NeuSpera Medical

San Jose, California, United States

NeuSpera Medical is a manufacturing firm that designs, manufactures, and sells implantable neuromodulation medical devices.

Machinery ManufacturingMedical DeviceProduct Design
Series DJul 15, 2024
Amount Raised: $23,000,000
Presidio Medical

South San Francisco, California, United States

Presidio Medical is a medtech company that develops a transformational neuromodulation platform.

Developer PlatformInformation TechnologyMedicalSoftware
Series CJun 26, 2023
Amount Raised: $72,000,000
Saluda Medical

Artarmon, New South Wales, Australia

Saluda Medical aims to improve the lives of people by providing personalized, responsive and efficient neuromodulation therapy.

Health CareMedicalMedical Device
Series UnknownApr 13, 2023
Amount Raised: $150,000,000
SetPoint Medical

Valencia, California, United States

SetPoint Medical develops novel therapeutics for the treatment of chronic autoimmune conditions.

BiotechnologyHealth CareMedicalTherapeutics
Series UnknownJan 19, 2023
Amount Raised: $80,000,000
Onc.AI

San Carlos, California, United States

Onc.AI is a software that specializes in clinical oncology, genomics, proteomics, and radiomics.

BiotechnologyHealth DiagnosticsMedicalOncologySoftware
Series AJan 5, 2023
Amount Raised: $25,000,000
Alpheus Medical

Oakdale, Pennsylvania, United States

Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.

BiotechnologyHealth CareHealth DiagnosticsMedical
Series ANov 10, 2022
Amount Raised: $14,000,000
MicroTransponder

Dallas, Texas, United States

MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases.

Health CareManufacturingMedicalMedical Device
Series EJun 20, 2022
Amount Raised: $73,000,000